Overview of human papillomavirus vaccination policy changes and its impact in the United States: Lessons learned and challenges for the future
- PMID: 33569854
- DOI: 10.1111/phn.12873
Overview of human papillomavirus vaccination policy changes and its impact in the United States: Lessons learned and challenges for the future
Abstract
Background: The HPV vaccination is effective and safe for preventing HPV infection and HPV attributable cancers. Despite this fact, the uptake rate of the vaccination in the United States has remained below the national target of 80%. Health policy focused on allocating resources and creating vaccine-promoting environments can influence HPV vaccination coverage rates. There is a scarcity of information about the HPV vaccination-related health policy and its impact on the outcome of vaccine uptake.
Method: We conducted a comprehensive review of HPV vaccination-related health policies at the federal, state, and professional organization levels and examined their impact on population health by reviewing national data on HPV vaccination uptake rates.
Results: The review revealed that (a) HPV vaccination recommendations, which serve as the federal-level HPV vaccination policy, have changed frequently in terms of gender, age criteria, and dosing schedule, and (b) the frequent changes of the policy have resulted in low uptake rates among male and young adult populations.
Discussion: The uptake rate should be continuously followed to evaluate the impact of recent changes to the federal-level HPV vaccination policy. State-level policies and healthcare professionals, including nurses, are important to the promotion of HPV vaccinations and decreasing HPV vaccination disparities.
Keywords: Papillomavirus vaccine; health policy; immunization; policy implementation; population health.
© 2021 Wiley Periodicals, Inc.
Similar articles
-
The association between state Medicaid expansion and human papillomavirus vaccination.Vaccine. 2020 Aug 27;38(38):5963-5965. doi: 10.1016/j.vaccine.2020.07.024. Epub 2020 Jul 22. Vaccine. 2020. PMID: 32709431
-
Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.Vaccine. 2020 Jan 29;38(5):954-962. doi: 10.1016/j.vaccine.2019.11.073. Epub 2019 Dec 13. Vaccine. 2020. PMID: 31843271 Review.
-
Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.J Adolesc Health. 2014 Nov;55(5):659-64. doi: 10.1016/j.jadohealth.2014.04.015. Epub 2014 Jun 10. J Adolesc Health. 2014. PMID: 24928803
-
Knowledge, attitudes, and practices related to human papillomavirus vaccination among college students in a state university: Implications for nurse practitioners.J Am Assoc Nurse Pract. 2020 Jun 23;33(9):709-718. doi: 10.1097/JXX.0000000000000431. J Am Assoc Nurse Pract. 2020. PMID: 32590447
-
Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature.Hum Vaccin Immunother. 2019;15(1):146-155. doi: 10.1080/21645515.2018.1512453. Epub 2018 Sep 6. Hum Vaccin Immunother. 2019. PMID: 30148974 Free PMC article. Review.
Cited by
-
Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women.Med Sci (Basel). 2022 Sep 13;10(3):52. doi: 10.3390/medsci10030052. Med Sci (Basel). 2022. PMID: 36135837 Free PMC article. Review.
-
Patient-Provider Health Communication Strategies: Enhancing HPV Vaccine Uptake among Adolescents of Color.Healthcare (Basel). 2023 Jun 10;11(12):1702. doi: 10.3390/healthcare11121702. Healthcare (Basel). 2023. PMID: 37372820 Free PMC article.
-
Determinants of HPV vaccine uptake intentions in Chinese clinical interns: an extended theory of planned behavior approach.Front Public Health. 2024 Feb 16;12:1345530. doi: 10.3389/fpubh.2024.1345530. eCollection 2024. Front Public Health. 2024. PMID: 38435300 Free PMC article.
-
Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review.Hum Vaccin Immunother. 2024 Dec 31;20(1):2429894. doi: 10.1080/21645515.2024.2429894. Epub 2024 Nov 29. Hum Vaccin Immunother. 2024. PMID: 39611606 Free PMC article. Review.
References
REFERENCES
-
- Abiola, S. E., Colgrove, J., & Mello, M. M. (2013). The politics of HPV vaccination policy formation in the United States. Journal of Health Politics, Policy and Law, 38(4), 645-681. https://doi.org/10.1215/03616878-2208567
-
- Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H.-R., Pirog, E. C., Guimerà, N., Hernandez-Suarez, G., Felix, A., Clavero, O., Lloveras, B., Kasamatsu, E., Goodman, M. T., Hernandez, B. Y., Laco, J., Tinoco, L., Geraets, D. T., Lynch, C. F., … de Sanjosé, S. (2015). Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. International Journal of Cancer, 136(1), 98-107. https://doi.org/10.1002/ijc.28963
-
- Ali, H., Guy, R. J., Wand, H., Read, T. R. H., Regan, D. G., Grulich, A. E., Fairley, C. K., & Donovan, B. (2013). Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infectious Diseases, 13, 140. https://doi.org/10.1186/1471-2334-13-140
-
- American Academy of Family Physicians. (2019). Disease- and population-specific immunizations: Human papillomavirus vaccine (HPV). https://www.aafp.org/patient-care/public-health/immunizations/disease-po...
-
- American Cancer Society. (2017). HPV campaign [Video file]. https://www.youtube.com/watch?v=S_nNo_vhMsk&list=PLRu0uHzo7TdJzR83_C...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical